Stockreport

Regenxbio to receive $370 mln upfront in gene therapy deal with AbbVie [Financial Post (Toronto, Ontario, Canada)]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF Shares of the Regenxbio, which could potentially receive up to $1.38 billion in milestone payments, jumped 26% to $41.75. 19 best online deals in the Canadian retail [Read more]